166 related articles for article (PubMed ID: 34128318)
1. Salvage surgery following downstaging of advanced non-small cell lung cancer by targeted therapy.
Li K; Cao X; Ai B; Xiao H; Huang Q; Zhang Z; Chu Q; Zhang L; Dai X; Liao Y
Thorac Cancer; 2021 Aug; 12(15):2161-2169. PubMed ID: 34128318
[TBL] [Abstract][Full Text] [Related]
2. Salvage surgery for advanced non-small cell lung cancer after targeted therapy: A case series.
Song W; Di S; Liu J; Fan B; Zhao J; Zhou S; Chen S; Dong H; Yue C; Gong T
Thorac Cancer; 2020 Apr; 11(4):1061-1067. PubMed ID: 32107870
[TBL] [Abstract][Full Text] [Related]
3. Salvage surgery for advanced non-small cell lung cancer following previous immunotherapy: a retrospective study.
Higuchi M; Inomata S; Yamaguchi H; Saito T; Suzuki H
J Cardiothorac Surg; 2023 Jul; 18(1):235. PubMed ID: 37475037
[TBL] [Abstract][Full Text] [Related]
4. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.
Greenhalgh J; Boland A; Bates V; Vecchio F; Dundar Y; Chaplin M; Green JA
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD010383. PubMed ID: 33734432
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors affecting survival in patients with non-small cell lung cancer treated with salvage surgery after drug therapy: a multi-institutional retrospective study.
Suzuki S; Asakura K; Okui M; Izawa N; Sawafuji M; Sakamaki H; Shigenobu T; Tajima A; Oka N; Masai K; Kaseda K; Hishida T; Yasuda H; Fukunaga K; Asamura H
World J Surg Oncol; 2023 Sep; 21(1):290. PubMed ID: 37715273
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of salvage chemotherapy in the advanced non-small cell lung cancer patients who failed the treatment of chemotherapy and EGFR-TKI].
Fan Y; Huang ZY; Yu HF; Luo LH
Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):859-63. PubMed ID: 21223694
[TBL] [Abstract][Full Text] [Related]
7. Preoperative chemoradiotherapy using cisplatin plus S-1 can induce downstaging in patients with locally advanced (stage III) non-small-cell lung cancer.
Kato M; Onishi H; Matsumoto K; Tsuruta N; Higuchi K; Motoshita J; Katano M
Anticancer Res; 2012 Nov; 32(11):5099-104. PubMed ID: 23155287
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Survival after Salvage Surgery for Local Failure after Definitive Chemoradiation Therapy for Locally Advanced Non-small Cell Lung Cancer.
Schreiner W; Dudek W; Lettmaier S; Fietkau R; Sirbu H
Thorac Cardiovasc Surg; 2018 Mar; 66(2):135-141. PubMed ID: 28992654
[TBL] [Abstract][Full Text] [Related]
9. Microwave ablation as local consolidative therapy for patients with extracranial oligometastatic EGFR-mutant non-small cell lung cancer without progression after first-line EGFR-TKIs treatment.
Ni Y; Ye X; Yang X; Huang G; Li W; Wang J; Han X; Wei Z; Meng M
J Cancer Res Clin Oncol; 2020 Jan; 146(1):197-203. PubMed ID: 31599340
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic Body Radiation Therapy as Salvage for Intrathoracic Recurrence in Patients With Previously Irradiated Locally Advanced Non-Small Cell Lung Cancer.
Parks J; Kloecker G; Woo S; Dunlap NE
Am J Clin Oncol; 2016 Apr; 39(2):147-53. PubMed ID: 24457534
[TBL] [Abstract][Full Text] [Related]
11. Local Consolidation Therapy (LCT) After First Line Tyrosine Kinase Inhibitor (TKI) for Patients With EGFR Mutant Metastatic Non-small-cell Lung Cancer (NSCLC).
Elamin YY; Gomez DR; Antonoff MB; Robichaux JP; Tran H; Shorter MK; Bohac JM; Negrao MV; Le X; Rinsurogkawong W; Lewis J; Lacerda L; Roarty EB; Swisher SG; Roth JA; Zhang J; Papadimitrakopoulou V; Heymach JV
Clin Lung Cancer; 2019 Jan; 20(1):43-47. PubMed ID: 30343004
[TBL] [Abstract][Full Text] [Related]
12. Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial.
Saito H; Fukuhara T; Furuya N; Watanabe K; Sugawara S; Iwasawa S; Tsunezuka Y; Yamaguchi O; Okada M; Yoshimori K; Nakachi I; Gemma A; Azuma K; Kurimoto F; Tsubata Y; Fujita Y; Nagashima H; Asai G; Watanabe S; Miyazaki M; Hagiwara K; Nukiwa T; Morita S; Kobayashi K; Maemondo M
Lancet Oncol; 2019 May; 20(5):625-635. PubMed ID: 30975627
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of concurrent versus sequential icotinib therapy and chemotherapy in advanced non-small cell lung cancer with sensitive EGFR mutations.
Zhang Y; Wang J; Yu Z; Ge H; Zhang LW; Feng LX
Clin Transl Sci; 2021 May; 14(3):890-897. PubMed ID: 33382908
[TBL] [Abstract][Full Text] [Related]
14. Salvage radiotherapy for regional lymph node oligo-recurrence after radical surgery of non-small cell lung cancer.
Seol KH; Lee JE; Cho JY; Lee DH; Seok Y; Kang MK
Thorac Cancer; 2017 Nov; 8(6):620-629. PubMed ID: 28906073
[TBL] [Abstract][Full Text] [Related]
15. Equivalent Outcome of Patients with Locally Advanced NSCLC Treated with Salvage Surgery Compared to Induction Chemotherapy Followed by Surgical Resection.
Uramoto H; Nakajima Y; Kinoshita H; Akiyama H
Anticancer Res; 2016 Aug; 36(8):4243-7. PubMed ID: 27466539
[TBL] [Abstract][Full Text] [Related]
16. [Value of surgery for stage IIIa non-small cell lung cancer].
Liu H; Wang M; Hu K; Xu Y; Ma M; Zhong W; Zhao J; Li L; Wang H
Zhongguo Fei Ai Za Zhi; 2013 Dec; 16(12):639-45. PubMed ID: 24345488
[TBL] [Abstract][Full Text] [Related]
17. Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer?
Schreiner W; Dudek W; Lettmaier S; Fietkau R; Sirbu H
J Cardiothorac Surg; 2016 Jan; 11():9. PubMed ID: 26781697
[TBL] [Abstract][Full Text] [Related]
18. Salvage pulmonary resection in stages IIIb-IV lung cancer after treatment with immune checkpoint inhibitors case series and literature review.
Smith A; Wali A; Montes A; Hadaki M; Harrison-Phipps K; Karapanagiotou EM; Bille A
J Surg Oncol; 2022 Feb; 125(2):290-298. PubMed ID: 34569618
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer.
Roth JA; Fossella F; Komaki R; Ryan MB; Putnam JB; Lee JS; Dhingra H; De Caro L; Chasen M; McGavran M
J Natl Cancer Inst; 1994 May; 86(9):673-80. PubMed ID: 8158698
[TBL] [Abstract][Full Text] [Related]
20. Thoracoscopic radical resection in the treatment of NSCLC patients (stage IIIA) after neoadjuvant chemotherapy.
Zhao L; Zhang L; Gong F; Xu J
J BUON; 2021; 26(2):313-319. PubMed ID: 34076974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
